AI Biotech, BioXcel Therapeutics, Files for $69M IPO Post author:Sam Post published:February 12, 2018 Post category:BioPharma The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace You Might Also Like Harvard???s Ph.D., A Leader In Alzheimer???s Disease Genetics, Joins Cerevance???s Advisory Board October 11, 2017 Race Heats Up As Mallinckrodt Gets Bids August 8, 2017 Oregon Bioscience Association Release: Oregon???s Life Science Industry On Display: Oregon Bioscience Showcase 2017 September 20, 2017
Harvard???s Ph.D., A Leader In Alzheimer???s Disease Genetics, Joins Cerevance???s Advisory Board October 11, 2017
Oregon Bioscience Association Release: Oregon???s Life Science Industry On Display: Oregon Bioscience Showcase 2017 September 20, 2017